0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query ark patent intelligence itraconazole patent extension data exclusivity expiry snapshot 9.Your search for "" gave back 1493368 results.
Itraconazole(CAS：84625-61-6) is an antifungal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global Pharmaceutical Grade Itraconazole market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Itraconazole(CAS：84625-61-6) is an antifungal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Itraconazole is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Pharmaceutical Grade Itraconazole market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Itraconazole is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Pharmaceutical Grade Itraconazole market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow...
Catalog:
LPI
May 2023
Price: USD 3,660.00
Itraconazole is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Pharmaceutical Grade Itraconazole market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Jumbo SA - Strategy, SWOT and Corporate Finance Report Summary Jumbo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive...
Catalog:
MarketLine
August 2022
Price: USD 175.00
Six Flags Entertainment Corp - Strategy, SWOT and Corporate Finance Report Summary Six Flags Entertainment Corp - Strategy, SWOT and Corporate...
Catalog:
MarketLine
May 2022
Price: USD 175.00
American National Insurance Co - Strategy, SWOT and Corporate Finance Report Summary American National Insurance Co - Strategy, SWOT and Corporate...
Catalog:
MarketLine
June 2021
Price: USD 175.00
Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive...
Catalog:
MarketLine
February 2022
Price: USD 175.00
Sally Beauty Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sally Beauty Holdings, Inc. - Strategy, SWOT and Corporate Finance...
Catalog:
MarketLine
January 2019
Price: USD 175.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
